ID   UBA7_HUMAN              Reviewed;        1012 AA.
AC   P41226; Q9BRB2;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   10-MAY-2017, entry version 166.
DE   RecName: Full=Ubiquitin-like modifier-activating enzyme 7;
DE            Short=Ubiquitin-activating enzyme 7;
DE   AltName: Full=D8;
DE   AltName: Full=Ubiquitin-activating enzyme E1 homolog;
GN   Name=UBA7; Synonyms=UBE1L, UBE2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=B-cell;
RX   PubMed=8327486; DOI=10.1073/pnas.90.13.6071;
RA   Kok K., Hofstra R., Pilz A., van den Berg A., Terpstra P.,
RA   Buys C.H.C.M., Carritt B.;
RT   "A gene in the chromosomal region 3p21 with greatly reduced expression
RT   in lung cancer is similar to the gene for ubiquitin-activating
RT   enzyme.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:6071-6075(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7734949;
RA   Kok K., Van den Berg A., Veldhuis P.M., Franke M., Terpstra P.,
RA   Buys C.H.C.M.;
RT   "The genomic structure of the human UBE1L gene.";
RL   Gene Expr. 4:163-175(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-17.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [7]
RP   PROTEIN SEQUENCE OF 973-987, INTERACTION WITH G1P2, AND PATHWAY.
RX   PubMed=11157743; DOI=10.1093/emboj/20.3.362;
RA   Yuan W., Krug R.M.;
RT   "Influenza B virus NS1 protein inhibits conjugation of the interferon
RT   (IFN)-induced ubiquitin-like ISG15 protein.";
RL   EMBO J. 20:362-371(2001).
RN   [8]
RP   FUNCTION.
RX   PubMed=16254333; DOI=10.1128/JVI.79.22.13974-13983.2005;
RA   Lenschow D.J., Giannakopoulos N.V., Gunn L.J., Johnston C.,
RA   O'Guin A.K., Schmidt R.E., Levine B., Virgin H.W. IV;
RT   "Identification of interferon-stimulated gene 15 as an antiviral
RT   molecule during Sindbis virus infection in vivo.";
RL   J. Virol. 79:13974-13983(2005).
RN   [9]
RP   FUNCTION.
RX   PubMed=20133869; DOI=10.1073/pnas.0909144107;
RA   Zhao C., Hsiang T.Y., Kuo R.L., Krug R.M.;
RT   "ISG15 conjugation system targets the viral NS1 protein in influenza A
RT   virus-infected cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:2253-2258(2010).
RN   [10]
RP   ISGYLATION.
RX   PubMed=22693631; DOI=10.1371/journal.pone.0038294;
RA   Bade V.N., Nickels J., Keusekotten K., Praefcke G.J.;
RT   "Covalent protein modification with ISG15 via a conserved cysteine in
RT   the hinge region.";
RL   PLoS ONE 7:E38294-E38294(2012).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-266, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Activates ubiquitin by first adenylating with ATP its C-
CC       terminal glycine residue and thereafter linking this residue to
CC       the side chain of a cysteine residue in E1, yielding a ubiquitin-
CC       E1 thioester and free AMP. Catalyzes the ISGylation of influenza A
CC       virus NS1 protein. {ECO:0000269|PubMed:16254333,
CC       ECO:0000269|PubMed:20133869}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000269|PubMed:11157743}.
CC   -!- SUBUNIT: Monomer (By similarity). Binds and is involved in the
CC       conjugation of G1P2/ISG15. {ECO:0000250}.
CC   -!- INTERACTION:
CC       P05161:ISG15; NbExp=10; IntAct=EBI-751921, EBI-746466;
CC   -!- TISSUE SPECIFICITY: Expressed in a variety of normal and tumor
CC       cell types, but is reduced in lung cancer cell lines.
CC   -!- PTM: ISGylated. {ECO:0000269|PubMed:22693631}.
CC   -!- MISCELLANEOUS: There are two active sites within the E1 molecule,
CC       allowing it to accommodate two ubiquitin moieties at a time, with
CC       a new ubiquitin forming an adenylate intermediate as the previous
CC       one is transferred to the thiol site.
CC   -!- SIMILARITY: Belongs to the ubiquitin-activating E1 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L13852; AAA75388.1; -; mRNA.
DR   EMBL; AF294032; AAG49557.1; -; Genomic_DNA.
DR   EMBL; BT007026; AAP35672.1; -; mRNA.
DR   EMBL; CH471055; EAW65023.1; -; Genomic_DNA.
DR   EMBL; BC006378; AAH06378.1; -; mRNA.
DR   CCDS; CCDS2805.1; -.
DR   RefSeq; NP_003326.2; NM_003335.2.
DR   UniGene; Hs.16695; -.
DR   ProteinModelPortal; P41226; -.
DR   SMR; P41226; -.
DR   BioGrid; 113166; 10.
DR   DIP; DIP-60526N; -.
DR   IntAct; P41226; 5.
DR   MINT; MINT-1454413; -.
DR   STRING; 9606.ENSP00000333266; -.
DR   BindingDB; P41226; -.
DR   ChEMBL; CHEMBL2321623; -.
DR   iPTMnet; P41226; -.
DR   PhosphoSitePlus; P41226; -.
DR   BioMuta; UBA7; -.
DR   DMDM; 215273977; -.
DR   EPD; P41226; -.
DR   MaxQB; P41226; -.
DR   PaxDb; P41226; -.
DR   PeptideAtlas; P41226; -.
DR   PRIDE; P41226; -.
DR   DNASU; 7318; -.
DR   Ensembl; ENST00000333486; ENSP00000333266; ENSG00000182179.
DR   GeneID; 7318; -.
DR   KEGG; hsa:7318; -.
DR   UCSC; uc003cxr.4; human.
DR   CTD; 7318; -.
DR   DisGeNET; 7318; -.
DR   GeneCards; MIR5193; -.
DR   GeneCards; UBA7; -.
DR   HGNC; HGNC:12471; UBA7.
DR   HPA; CAB015444; -.
DR   HPA; HPA058182; -.
DR   MIM; 191325; gene.
DR   neXtProt; NX_P41226; -.
DR   OpenTargets; ENSG00000182179; -.
DR   PharmGKB; PA162407761; -.
DR   eggNOG; KOG2012; Eukaryota.
DR   eggNOG; COG0476; LUCA.
DR   GeneTree; ENSGT00390000016689; -.
DR   HOGENOM; HOG000167329; -.
DR   HOVERGEN; HBG054199; -.
DR   InParanoid; P41226; -.
DR   KO; K10698; -.
DR   OMA; FPPLHYE; -.
DR   OrthoDB; EOG091G0130; -.
DR   PhylomeDB; P41226; -.
DR   TreeFam; TF300586; -.
DR   Reactome; R-HSA-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-HSA-168928; RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways.
DR   Reactome; R-HSA-5656169; Termination of translesion DNA synthesis.
DR   Reactome; R-HSA-936440; Negative regulators of RIG-I/MDA5 signaling.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; UBA7; human.
DR   GeneWiki; UBE1L; -.
DR   GenomeRNAi; 7318; -.
DR   PRO; PR:P41226; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000182179; -.
DR   CleanEx; HS_UBA7; -.
DR   Genevisible; P41226; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019782; F:ISG15 activating enzyme activity; IDA:HGNC.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; EXP:Reactome.
DR   GO; GO:0006464; P:cellular protein modification process; IDA:HGNC.
DR   GO; GO:0032020; P:ISG15-protein conjugation; IDA:HGNC.
DR   GO; GO:0019941; P:modification-dependent protein catabolic process; IEA:Ensembl.
DR   GO; GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome.
DR   GO; GO:0019985; P:translesion synthesis; TAS:Reactome.
DR   InterPro; IPR032420; E1_4HB.
DR   InterPro; IPR032418; E1_FCCH.
DR   InterPro; IPR000594; ThiF_NAD_FAD-bd.
DR   InterPro; IPR018965; Ub-activating_enz_E1_C.
DR   InterPro; IPR019572; UBA_E1_Cys.
DR   InterPro; IPR018075; UBQ-activ_enz_E1.
DR   InterPro; IPR033127; UBQ-activ_enz_E1_Cys_AS.
DR   InterPro; IPR000011; UBQ/SUMO-activ_enz_E1-like.
DR   Pfam; PF16191; E1_4HB; 1.
DR   Pfam; PF16190; E1_FCCH; 1.
DR   Pfam; PF09358; E1_UFD; 1.
DR   Pfam; PF00899; ThiF; 2.
DR   Pfam; PF10585; UBA_e1_thiolCys; 1.
DR   PRINTS; PR01849; UBIQUITINACT.
DR   SMART; SM00985; UBA_e1_C; 1.
DR   SUPFAM; SSF69572; SSF69572; 2.
DR   TIGRFAMs; TIGR01408; Ube1; 1.
DR   PROSITE; PS00865; UBIQUITIN_ACTIVAT_2; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Direct protein sequencing; Ligase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Ubl conjugation; Ubl conjugation pathway.
FT   CHAIN         1   1012       Ubiquitin-like modifier-activating enzyme
FT                                7.
FT                                /FTId=PRO_0000194937.
FT   REPEAT       23    159       1-1.
FT   REPEAT      423    575       1-2.
FT   NP_BIND     442    471       ATP. {ECO:0000250}.
FT   REGION       23    575       2 approximate repeats.
FT   ACT_SITE    599    599       Glycyl thioester intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10132}.
FT   MOD_RES     266    266       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VARIANT     712    712       P -> S (in dbSNP:rs11928913).
FT                                /FTId=VAR_052434.
FT   VARIANT     817    817       H -> R (in dbSNP:rs2230149).
FT                                /FTId=VAR_047793.
FT   CONFLICT    355    378       GVLSPMVAMLGAVAAQEVLKAISR -> RCLEPMVACWVSS
FT                                CPGSAEGNLQ (in Ref. 1; AAA75388 and 2;
FT                                AAG49557). {ECO:0000305}.
SQ   SEQUENCE   1012 AA;  111694 MW;  A01E1106D81778EB CRC64;
     MDALDASKLL DEELYSRQLY VLGSPAMQRI QGARVLVSGL QGLGAEVAKN LVLMGVGSLT
     LHDPHPTCWS DLAAQFLLSE QDLERSRAEA SQELLAQLNR AVQVVVHTGD ITEDLLLDFQ
     VVVLTAAKLE EQLKVGTLCH KHGVCFLAAD TRGLVGQLFC DFGEDFTVQD PTEAEPLTAA
     IQHISQGSPG ILTLRKGANT HYFRDGDLVT FSGIEGMVEL NDCDPRSIHV REDGSLEIGD
     TTTFSRYLRG GAITEVKRPK TVRHKSLDTA LLQPHVVAQS SQEVHHAHCL HQAFCALHKF
     QHLHGRPPQP WDPVDAETVV GLARDLEPLK RTEEEPLEEP LDEALVRTVA LSSAGVLSPM
     VAMLGAVAAQ EVLKAISRKF MPLDQWLYFD ALDCLPEDGE LLPSPEDCAL RGSRYDGQIA
     VFGAGFQEKL RRQHYLLVGA GAIGCELLKV FALVGLGAGN SGGLTVVDMD HIERSNLSRQ
     FLFRSQDVGR PKAEVAAAAA RGLNPDLQVI PLTYPLDPTT EHIYGDNFFS RVDGVAAALD
     SFQARRYVAA RCTHYLKPLL EAGTSGTWGS ATVFMPHVTE AYRAPASAAA SEDAPYPVCT
     VRYFPSTAEH TLQWARHEFE ELFRLSAETI NHHQQAHTSL ADMDEPQTLT LLKPVLGVLR
     VRPQNWQDCV AWALGHWKLC FHYGIKQLLR HFPPNKVLED GTPFWSGPKQ CPQPLEFDTN
     QDTHLLYVLA AANLYAQMHG LPGSQDWTAL RELLKLLPQP DPQQMAPIFA SNLELASASA
     EFGPEQQKEL NKALEVWSVG PPLKPLMFEK DDDSNFHVDF VVAAASLRCQ NYGIPPVNRA
     QSKRIVGQII PAIATTTAAV AGLLGLELYK VVSGPRPRSA FRHSYLHLAE NYLIRYMPFA
     PAIQTFHHLK WTSWDRLKVP AGQPERTLES LLAHLQEQHG LRVRILLHGS ALLYAAGWSP
     EKQAQHLPLR VTELVQQLTG QAPAPGQRVL VLELSCEGDD EDTAFPPLHY EL
//
